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Assessing influenza A virus strains circulating in ani-
mals and their potential to cross the species barrier and 
cause human infections is important to improve human 
influenza surveillance and preparedness. We reviewed 
studies describing serological evidence of human 
exposure to animal influenza viruses. Comparing sero-
logical data is difficult due to a lack of standardisa-
tion in study designs and in laboratory methods used 
in published reports. Therefore, we designed a scor-
ing system to assess and weigh specificity of obtained 
serology results in the selected articles. Many studies 
report reliable evidence of antibodies to swine influ-
enza viruses among persons occupationally exposed 
to pigs. Most avian influenza studies target H5, H7 
and H9 subtypes and most serological evidence of 
human exposure to avian influenza viruses is reported 
for these subtypes. Avian influenza studies receiving 
a low grade in this review often reported higher sero-
prevalences in humans compared with studies with a 
high grade. Official surveillance systems mainly focus 
on avian H5 and H7 viruses. Swine influenza viruses 
and avian subtypes other than H5 and H7 (emphasis-
ing H9) should be additionally included in official sur-
veillance systems. Surveillance efforts should also be 
directed towards understudied geographical areas, 
such as Africa and South America.
Introduction
The family Orthomyxoviridae contains three distinct 
genera of influenza: A, B and C. Influenza A and B 
viruses are known to cause high human morbidity and 
mortality during the yearly seasonal epidemics. In con-
trast to influenza B viruses, influenza A viruses circu-
late in many animal species and are able to cross the 
species barrier, in particular from animal to human. 
This can occur either directly, or after a unique type of 
reassortment that results in the generation of viruses 
that are able to replicate in humans and have haemag-
glutinin (HA) genes (and less frequently neuramini-
dase (NA) genes) that are antigenetically distinct from 
those of seasonal influenza viruses (antigenic shift) 
[1]. Viruses resulting from ‘antigenic shift’ have caused 
four influenza pandemics in the past 100 years: the 
‘Spanish flu’ A(H1N1) in 1918, the ‘Asian flu’ A(H2N2) 
in 1957, the ‘Hong Kong flu’ A(H3N2) in 1968, and most 
recently the A(H1N1)pdm09 pandemic in 2009 [1].
Animal influenza viruses are of concern because of the 
small but real risk of their adaptation to humans, possi-
bly leading to efficient human-to-human transmission 
and sustainable circulation in the human population. It 
has been suggested that rising global trade and travel 
and changes in human demographics, consumption 
patterns and behaviours have caused an increase of 
emerging infectious diseases in general, and zoonotic 
influenza in particular [2-5]. Well-known examples of 
animal influenza viruses that have recently infected 
humans include A(H5N1), A(H6N1), A(H7N9), A(H9N2) 
and A(H10N8) [6].
To improve human influenza surveillance and prepar-
edness, it is important to be able to assess influenza 
A virus strains circulating in the animal population as 
to their potential to cross the species barrier and cause 
human infections. The first step is to collect and review 
existing scientific studies that assess the prevalence of 
zoonotic influenza in human populations. Recently, a 
comprehensive literature review listed published viro-
logical evidence for human infection with swine and 
avian influenza viruses other than A(H5N1) [6].
While surveillance based on virologically-confirmed 
human influenza cases has a high positive predictive 
value, the approach has some downsides. Virus shed-
ding in infected persons typically lasts only a week and 
has often diminished or ended by the time of sampling 
[7]. In addition, infections may cause only mild ill-
ness, leading to cases possibly remaining undetected. 
Studies investigating serological evidence of infection 
have a wider window of detection and have been used 
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to study exposure in human–animal interface settings. 
A pitfall is that serological data need to be interpreted 
with caution due to cross-reactivity of antibodies 
among and within virus subtypes and the problems of 
sensitivity and reliability of standard serological tests 
when used to detect antibodies against novel influ-
enza subtypes [8-11].
In this review, we assess studies describing serologi-
cal evidence of human infection with animal influenza 
viruses. A scoring system was developed to assess 
the specificity of the obtained serology results in the 
selected articles, taking into account both the study 
design and the laboratory method used. This scoring 
system was used to weigh the serological evidence 
for animal influenza exposure in humans. This review 
can serve as input for an evidence-based risk assess-
ment framework to evaluate novel influenza viruses 
or variants in light of their potential to create human 
outbreaks.
Methods
Search strategy and selection criteria
We performed a comprehensive literature search for 
serological studies dealing with zoonotic influenza, 
using the same search strategy as described in Freidl 
et al. 2014, but expanding the search period up to 
February 2014 [6]. The total period covered was from 
1946 to February 2014. We additionally conducted 
a more cursory search to include studies published 
between February and December 2014.
Two investigators first screened all recovered publica-
tions by title and, when necessary, by abstract. They 
selected reports presenting serological evidence from 
observational studies describing human infection with 
animal influenza viruses. Studies of influenza A(H5N1) 
were excluded, as serological evidence of H5N1 in 
humans has been extensively reviewed previously 
[12,13].
The selected studies excluded those describing influ-
enza antibody findings only in animals and those 
reporting only human-to-human transmission of ani-
mal influenza viruses. We also disregarded reviews, 
commentaries, and articles describing data that were 
described in previous publications.
Scoring the quality of the evidence
To be able to assess the value of the outcomes of 
the selected studies, we developed a scoring system 
(Table 1, Table 2). For this, we identified important 
parameters for the evaluation of the specificity of 
results from observational studies describing serologi-
cal evidence of human exposure to animal influenza 
viruses (i.e. study design, laboratory method used, 
background data on vaccination, exposure data). 
Subsequently we defined subsets for each parameter, 
based on review of the literature and Consortium for 
the Standardization of Influenza Seroepidemiology 
(CONSISE) and World Health Organization (WHO) rec-
ommendations [14,15,16]. Finally we assigned arbitrary 
points for considered parameters (or subsets thereof) 
to allow each individual study to be assigned a score; 
the score of a study was obtained by summing up the 
points corresponding to the parameters considered 
in that study. The final scoring system was discussed 
with virologists and epidemiologists from Erasmus 
University Medical Center (ErasmusMC) and Oxford 
University Clinical Research Unit (OUCRU) in Vietnam.
The maximum score that a study could obtain was 18. 
A detailed breakdown of the scoring system is shown 
in Table 1. Based on their overall score, we assigned all 
studies into four categories (A, B, C, D), ranging from 
best to worst. Category A spanned studies with scores 
ranging from 15 to 18 points, category B from 10 to 14 
points, category C from 5 to 9 points and category D 
from 0 to 4 points.
Rationale of the scoring system
In our scoring system, studies including a control 
group matched for age (less than 10 years difference in 
average age), sex (less than 10% difference in the per-
centage of women and men) and area (same country) 
received a higher score (Table 1: 6 of 18), as age, sex 
and location are possible confounding factors for influ-
enza serology [17-20]. The inclusion of an age-stratified 
control group is also recommended by the CONSISE 
[14]. A control group is of particular interest for zoonotic 
influenza serology, because influenza infections occur 
repeatedly over a human lifetime, boosting pre-exist-
ing antibodies against human influenza viruses which 
might cross-react with animal influenza virus subtypes 
[21-26]. Comparison of an animal-exposed study popu-
lation with a well-defined non-animal-exposed control 
group is important to avoid over-estimation of the sig-
nificance of the serological findings. We also assigned 
a higher score to studies that did not include an age-
matched control group but did report the age of study 
participants and corrected their results for age dif-
ferences, or to studies that stratified their findings in 
separate age groups.
An antibody titre rise between two samples from the 
same individual was considered a more reliable meas-
ure of infection than obtained by a single serum sam-
ple, as individuals served as their own control.
A higher score was assigned to studies which 
addressed the possibility that antibodies may result 
from cross-reactivity among influenza subtypes. These 
studies included vaccination rates and/or tested for 
human influenza types, both variables known to have 
an effect on the generation of cross-reactive antibod-
ies [17,27]. In order to score all studies in an objective 
manner, we did not evaluate their analysis of cross-
reactivity but assigned scores based only on their 
inclusion of vaccination rate and/or testing for any 
human influenza type.
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A higher score was also assigned to studies that added 
non-serological evidence of exposure of humans, par-
ticularly when they provided virological evidence for 
infection with animal influenza in their human study 
participants or in the animal population to which the 
participants had been exposed.
The rationale for our scoring of the laboratory meth-
ods used in the studies that we reviewed is based on 
the official WHO case definitions for human infections 
with influenza A(H5N1) virus [15]. A confirmed case, 
according to WHO, has a fourfold or greater rise in neu-
tralisation antibody titre or a microneutralisation (MN) 
Figure 1
Geographical origin of animal influenza serological studies in humans, 1946–2014 (n=94 studies)
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antibody titre of 1:80 or greater and a positive result 
using a different serological assay for example a hae-
magglutination inhibition (HI) titre of 1:160 or greater 
or a specific Western blot positive result.
Therefore studies that used both HI and neutralisa-
tion assays received the highest scores possible [5] 
as well as neutralisation assays that were confirmed 
with Western blot or enzyme-linked immunosorbent 
assay (ELISA) tests (Table 2). Moreover, studies using 
a confirmation test scored higher than studies that 
did not include a second serological assay to con-
firm their results. A single neutralisation test received 
three points in part because the WHO considers the 
MN assay to be the recommended test for measuring 
antibodies against highly pathogenic avian influenza 
A viruses. The MN test is an assay with high specific-
ity [28]. The HI test is also a reliable serological test 
for influenza antibodies, and studies using this assays 
therefore receive the second highest score. The NA 
inhibition (NI) test can play a role in confirmation of 
influenza A subtypes but is not sufficient as screening 
test or if used as the only serological assay.
Analysis of the data
All statistical analyses were performed in STATA 
(StataSE 13.0). For all analyses, a p-value of less than 
0.05 was considered statistically significant.
Results
Search output
The final output of the literature search was 94 arti-
cles [10,18,19,29-119] (Table 3). Some articles could 
describe more than one study design, animal species, 
or influenza A subtype. Included were 12 prospective 
cohort studies, 13 cross-sectional studies in the gen-
eral population or in rural populations, 57 cross-sec-
tional studies in populations with routine exposure 
to animals, nine cross-sectional studies in hospital 
populations, and 11 animal influenza outbreak inves-
tigations. We found one report on an investigation of 
human serological evidence for canine influenza, four 
studies for equine influenza, 39 for swine influenza, 
and 56 for avian influenza A. The majority of the stud-
ies investigated serological evidence for antibodies to 
avian subtypes with HA-type H9 (43 articles), H7 (40 
articles), H5 (excluding H5N1, 27 articles), and swine 
influenza subtype H1N1variant (H1N1v) (36 articles) 
(Table 3). 
Study populations were from Asia (n = 37), North 
America (n = 28), Europe (n = 19), and the Middle East 
(n = 7, of which 5 were from Iran). For Africa, Oceania 
and South America, the search yielded only one publi-
cation for each. In North America, most studies focused 
on human infections with swine influenza, whereas in 
other parts of the world, such as Asia, more emphasis 
was placed on avian influenza viruses (Figure 1).
In studies investigating swine influenza, the HI test 
was used more frequently, while studies that meas-
ured human antibodies against avian influenza viruses 
more often made use of neutralisation tests. Moreover, 
only studies published in the last decade used neutral-
isation as single diagnostic test. The use of NI assays 
on the other hand was only described in one of 72 
included articles that were published after 2000, com-
pared with seven of 22 studies that were published in 
the year 2000 or before (Figure 2).
Description of positive cases according to the WHO 
confirmed case definition could only be extracted from 
11 articles [50,55,69,80,87,89,91,99,111,112,115]. These 
articles used the appropriate diagnostics tests and 
either reported the antibody titres or used the appro-
priate cut offs when describing the results.
Scoring the studies
An overview of the scoring of all studies investigat-
ing serological evidence of swine and avian influenza 
viruses in humans is presented in Figures 2 and 3, 
respectively. Assuming an arbitrary quality threshold 
at 9 points (half the maximum score), only 24% of the 
studies (n = 23) were graded A or B, of which only one 
met the requirements for grade A. A total of 57% (n = 53) 
and 19% (n = 18) of the studies fell into category C and 
D, respectively. All but four grade A and B studies had 
a control group that was matched for at least two of 
the three desired characteristics (age, sex and area). 
Figure 2
Diagnostic methods used in serological studies 
investigating animal influenza exposure of humans 
according to time period, 1946–2014 (n=94 studies)
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Figure 3
Scoring results of the included swine and avian influenza serological studies in humans, 1946–2014 (n=94 studies)
d
a Reference numbers 51,54,70,73,79,96,103.
b Reference numbers 64,66,84,89,98,99,101,111,114.
c Reference numbers 59,60,65,71,78,100,108.
d Reference numbers of studies with significant difference between experimental and control group are also underlined.
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Such controls were missing or insufficiently matched 
for most of the grade C studies and all of the grade D 
studies. The second marked difference was the fact 
that grade A and B studies more often included a sero-
logical confirmation test compared with C and D stud-
ies. Of the 23 studies graded A or B, eight investigated 
serological evidence for swine influenza (H1N1v, H1N2 
variant (H1N2v), H2N3 variant (H2N3v), and H3N2variant 
(H3N2v)), 14 pertained to avian influenza viruses (H4–
H16), and one study investigated human antibodies 
against a canine influenza virus (H3N8). Studies that 
fell into category A or B were all published relatively 
recently: category A or B swine influenza studies were 
all published in 2010 or later, and category A or B avian 
influenza studies were all published in or after 2006.
Swine influenza
Cross-sectional studies
The vast majority of the swine influenza sero-epide-
miological studies detected antibodies in a proportion 
of the population under investigation (32/35 of stud-
ies looking for H1N1v antibodies, 6/6 for H1N2v, and 
9/11 for H3N2v) (Table 3). When single serum samples 
were analysed, cut-off values of serological assays 
(HI-assays and neutralisation assays) ranged from 1:10 
to 1:100. For paired sera, a fourfold titre rise was con-
sidered proof of infection, but in cohort studies any 
titre increase during the study period was reported. The 
reported seroprevalences differed greatly among stud-
ies. In populations occupationally exposed to swine, 
the prevalence of antibodies to H1N1v ranged from 
0% to almost 80% [82,85], to H1N2v from 4% to 67% 
[72,82] and to H3N2v from 9% to almost 80% [49,72]. 
Looking only at the high quality studies (grades A or 
B), the reported prevalences were similar to those for C 
and D studies, with the exception of H3N2v, for which 
the highest reported seroprevalence was 28% [74] 
(Figure 4). In the unexposed control groups the anti-
body prevalence to H1N1v ranged from 0% to 18.7% 
[31,88]. One study, published in 1968, found a sero-
prevalence to H1N1v of 67.4% in the general popula-
tion, but this could be explained by cross-reacting 
antibodies against the 1918 pandemic influenza virus 
in the older population [30]. For H1N2v and H3N2v 
the prevalence in the general population and control 
groups ranged between 1.0% and 11.4% and between 
0% and 85.0%, respectively [49,72,74].
In studies that investigated the difference between an 
unexposed control group and the study population (i.e. 
study participants exposed to animals), a significantly 
higher number of seropositive people was found in the 
study population of 13 of 18 of the H1N1v studies, five 
of six of the H1N2v studies, and three of seven of the 
H3N2v studies.
Cohort studies
Woods et al. and Terebuh et al. found titre increases 
in antibodies against H1N1v of 0% to 8.5% per year in 
serum of farm workers and abattoir workers exposed 
to swine [43,74]. Gray et al. found that 25% of rural 
residents showed a fourfold increase in antibodies to 
H1N1v over a two year period from 2004 to 2006 [58]. 
Slightly lower rates were found for H1N2v, for which 
5% (fourfold antibody titre increase, rural residents) 
and 8% (antibody titre rise, farm workers and abattoir 
workers) of study participants had evidence of expo-
sure over two years [58,74]. In the period from 2008 
to 2011, both Coman et al. and Gray et al. found a high 
percentage of seroconversions for H1N1v and H1N2v, 
which were most likely due to cross-reactions with 
influenza A(H1N1)pdm09 [117,118]. Both Coman et al. 
and Terebuh et al. investigated serological evidence 
of H3N2v exposure during a time-period of two years, 
concluding that the number of titre increases for differ-
ent types of H3N2v in the swine-exposed group were 
not significantly higher than in control groups [74,117].
Outbreak studies
The five outbreak studies included in this review tar-
geted people who were exposed to swine infected 
with swH1N1 (n = 4) or swH2N3 (n = 1). Those that 
investigated people exposed to swH1N1 reported sero-
prevalences ranging from 15% to 40% (using various 
cut-offs), and three of four reported a significant dif-
ference between the exposed individuals and a con-
trol group [40,44,46,75]. All four H1N1v studies were 
graded C, except the study by DaWood et al., which 
received grade B. It reported that 40% of pig-exposed 
study participants had a MN titre ≥ 80 and HI titre ≥ 20 
[75]. The one study of H2N3v, graded A, investigated 
workers who were exposed to H2N3-infected swine 
and found, remarkably, a higher seroprevalence in the 
unexposed control group [19].
Avian influenza
Cross-sectional studies
Most studies screening for antibodies against avian 
influenza viruses failed to detect antibodies in any pro-
portion of the population under investigation, except 
for subtype H9 to which 36 of 43 studies detected anti-
bodies. The cut-off values for neutralisation tests used 
in the studies ranged from 1:2 to 1:160 for HI and 1:10 
to 1:80. In the cross-sectional studies over all, antibod-
ies were detected against avian influenza A virus HA 
subtypes H1 through H13. However, in studies graded 
A or B, fewer subtypes were detected: H5, H6, H7, H9, 
H10, H11 and H12 (Figure 5).
When reviewing only studies that compared prevalence 
of antibodies in risk groups (subjects in contact with 
animals) with those from a control group, some stud-
ies found significant differences in seroprevalence 
between both groups for avian influenza subtypes H4 
(1 of 14 studies; 1/14), H5 (4/16), H6 (2/13), H7 (6/23), 
H8 (1/11), H9 (13/29), and H10 (1/12). Insufficient stand-
ardisation or description of methods and cut-offs did 
not allow a direct comparison of the data.
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Studies with a lower score (C or D) appeared to report 
higher prevalences for avian influenza antibodies than 
did A or B studies, but the difference was not signifi-
cant (p > 0.05). Our conclusions were similar when we 
compared different cut-offs.
Cross-sectional studies: grade A and B studies
Most grade A and grade B studies reported serological 
evidence of H5, H7 and H9 exposure, but with consid-
erable variation. Gray et al. found a significant dif-
ference in the seroprevalence of H5N2 antibodies in 
a swine- and poultry-exposed rural population from 
Iowa, United States, vs unexposed controls from the 
same region (8.8 vs 0%) [63]. Okoye et al. found H5N2 
antibodies in poultry-exposed and -unexposed groups 
from Nigeria (0.3 vs 1.8%), however, this difference was 
not significant [63,102]. Moreover, two studies exe-
cuted in Romania and Vietnam found no antibodies in 
either group [18,91]. Gray et al. also found neutralising 
antibodies to H6N2 and H7N2 influenza virus in the 
same study, but the prevalences were not significantly 
different between the exposed group and non-exposed 
controls (1.4 vs 4.0% and 5.5 vs 0%) [63]. Five other 
studies failed to find serological evidence of H6 or H7 
exposure [18,63,80,102,117]. Only one-cross sectional 
study looked at H7N9 exposure, finding a seropreva-
lence of 6.3% in poultry workers in Guangdong, China, 
and a significantly lower percentage in non-exposed 
controls (0%) [110]. Antibodies to H9N2 avian influenza 
virus were found in four of seven studies, with sero-
prevalences ranging from 1.3 to 12.3% [91,119]. Only 
Wang et al. found a significantly higher prevalence in 
exposed vs control persons in Shanghai, China (5.0 
vs 1.3%). Uyeki et al. included other H9 antigens and 
found a low level of antibodies to H9N3 and H9N7 virus 
in Vietnamese poultry workers, although the preva-
lences of 0.5% and 2.5%, respectively, were not sig-
nificantly different from the control group (0 and 3.5%) 
Figure 4
Seroprevalence of antibodies to different swine influenza viruses in exposed and control humans, 1946–2014 (n=39 studies)
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[91]. In 2013, Qi et al. found 0.4% prevalence of anti-
bodies to H10N8 in animal workers in Guangdong prov-
ince, China, which did not differ significantly from the 
non-exposed controls (0%) [112].
Cohort studies
A two-year study from Gray et al. in Iowa found 0.6% 
of swine and poultry unexposed agricultural workers 
experiencing an antibody increase for H4N8 during 
this time period, and 0.8% of exposed and unexposed 
agricultural workers experiencing an antibody increase 
for H5N2 [63]. Four cohort studies found antibodies 
to H6N1 during their two-year study periods. The per-
centage of the study populations that experienced an 
increase in antibody titres ranged between 0.1% and 
2% [101,108,117,118]. Two of the four studies could not 
find an association with animal exposure. A very low 
percentage (< 0.3%) of four of the study populations 
experienced a slight increase in antibodies against 
H4N6, H7N7, H10N4 or H12N5 [82,101,108,117].
Increases in H9N2 antibodies were detected in three 
two-year cohort studies investigating poultry workers. 
In Thailand, between 2008 and 2010, 2% of the study 
population seroconverted in the first year of the study, 
and 2.5% seroconverted in the second year [101]. A 
similar number of antibody titre increases was found in 
Mongolia between 2009 and 2011: 2.2% of the adults 
experienced an increase in antibodies after either year 
1 or year 2 of the study [108]. In both studies there 
were individuals that showed a fourfold antibody titre 
increase (0.3% and 0.8%) but did not report influenza-
like illness, suggesting subclinical infections [101,108]. 
Gray et al. found that 0.3% of agricultural workers from 
Iowa experienced a titre increase for H9N2 during the 
two-year study period [63].
Besides information about the number of seroconver-
sions, cohort studies provide information on antibody 
longevity. Lu et al. show that all individuals previously 
seropositive for H7N7 and H9N2 sera became seroneg-
ative after one year [64]. Krueger et al. likewise found 
that antibody titres against H6N1 and H7N7 were unde-
tectable after one year [101].
Outbreak investigations
The outbreak studies included in this review investi-
gated people who had been exposed to poultry infected 
with H5, H7, H9 or H10. A study of H5N2 outbreaks at 
Japanese chicken farms found a positive H5N2 neutral-
ising titre (MN ≥ 1:40) in 25% of the workers, of whom 
7.8% showed a fourfold antibody increase [65]. Di 
Trani et al. found that 2.1% of Italian poultry workers 
exposed to H5N2- or H5N7-infected poultry showed an 
antibody titre (HI ≥ 1:10), but results were not confirmed 
by MN, nor was there a significant difference between 
study participants and unexposed controls [87].
The outbreak studies that found H7 antibodies 
reported seroprevalences from 0.4 to 3.2% in exposed 
poultry workers [53,87]. The outbreak study by Di Trani 
et al. found significantly more antibodies to H7N1 and 
H7N3 in H7-exposed poultry workers compared with 
unexposed controls (3.2 vs 0.8%) [87]. Another out-
break investigation conducted in Italian poultry work-
ers likewise found H7N1 and H7N3 antibodies, in 0.4% 
and 2.2% of the workers respectively, but included no 
controls. Moreover, six of the 983 workers in that study 
reported conjunctivitis but showed no H7 antibody 
Figure 5
Seroprevalence of antibodies to different avian influenza viruses in exposed and control humans 1946–2014 (n=56 studies)
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response [53]. Using an MN assay with cut-off of 1:80, 
Skowronski et al. found no evidence for human anti-
body responses in Canadian workers involved in an 
H7N3 outbreak in poultry; but they reported that close 
contact with the infected poultry correlated with red or 
watery eyes [62]. In a study of H7N7 by Meijer et al. in 
the Netherlands, the results from the HI assay (≥ 1:10) 
indicated a prevalence of 49%, but none of the titre 
rises could be confirmed by MN; however, ocular symp-
toms of infection appeared more frequently in subjects 
with HI-detected antibodies compared with subjects 
without antibodies [10].
One outbreak study investigating H9-exposed poul-
try farmers found antibodies in 11 of 34 participants 
(32.3%), but did not include a control group or describe 
a cut-off for the HI assay [54]. Arzey et al. investigated 
abattoir workers exposed to H10N7-infected poultry 
and found that two of seven reporting conjunctivi-
tis were polymerase chain reaction (PCR)-positive for 
influenza A; partial sequence analysis of the HA con-
firmed the presence of H10 subtype, but the findings 
could not be serologically confirmed [86].
Equine and canine influenza
Two studies executed before 1970 in Europe investi-
gated human exposure to equine influenza viruses and 
found prevalences from 4.2% to 20.9% for H3N8, using 
HI and neutralisation assays, but no non-exposed 
control group was included [29,30]. Khurelbaatar et 
al. also investigated exposure to equine influenza 
virus in a Mongolian rural population during a period 
from 2009 to 2011 and found a seroprevalence of 1.1% 
at enrolment. During the two-year follow-up period, 
2.5% of the study population experienced a fourfold 
titre increase against equine influenza virus H3N8, 
but exposure to camels or horses was not associated 
with titres to H3N8 [100,108]. Antibody responses have 
been detected against canine influenza A(H3N8) in 
dog-exposed subjects, but comparison with an unex-
posed control group yielded no significant difference 
(20.7 vs 12.1%) [106].
Discussion
There is currently no methodology or tool available for 
the quality assessment and comparison of influenza 
serology population studies [120]. In this review we 
therefore tried to develop a grading system to weigh 
the evidence for human infection with animal influ-
enza viruses from the included studies. Each attribute 
of the grading system is either a known confounding 
factor, and should therefore be included in the analy-
sis or is an accepted method to improve the specificity 
of the outcome of serological influenza. Although the 
weights of variables of the scoring system were divided 
in an arbitrary manner, the scoring system comprises 
important factors that should be incorporated in future 
studies investigating human exposure by animal influ-
enza viruses to improve reliability of human serological 
evidence.
Table 1
Scoring system for evaluation of published reports describing seroprevalence studies of zoonotic influenza virus infections
Parameter Maximum score
Individual scores
0 1 2 3
Control group 6 No Unmatched
Age-matched (2)a 
Sex-matched (2)a 
Area-matched (2)a
NA
Repeated samplingb 2 No NA Yes NA
Correction for age or 
reporting of study 
participants’ age groupsc
1 No Yes NA NA
Human vaccination status 
reported 1 No Yes NA NA
Testing included human 
influenza type(s) 1 No Yes NA NA
Other evidence 3 No
Serological evidence in 
animals to which humans 
were exposed
Virological evidenced in 
animals to which humans 
were exposed
Virological evidenced in 
human study participants
Laboratory method 5 (Table 2) NA NA NA NA
Total 18 NA NA NA NA
NA: not applicable.
a Two points are added to the final scoring result for age-matched, sex-matched and area-matched controls (same country), adding up to a 
maximum score of six. 
b Sampling to assess changes in antibody levels.
c Score applied only if there was no age-matched control group.
d Virus detection by culture or (real-time) reverse transcription-polymerase chain reaction (rtRT-PCR) and sequencing is listed as virological 
evidence.
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It was often not possible to score all aspects of the 
execution of a study, as details were lacking from its 
methods section. For example, although we scored for 
the presence of information on confounding factors, we 
did not take into account how they were incorporated 
in the analysis of the data because the methodologi-
cal information was insufficient to allow this. Nor did 
we assess the quality and execution of the laboratory 
tests, because descriptions often omitted details that 
can very much influence test outcome, e.g. the origin 
and quality of red blood cells used in HI assays [121].
It is difficult to interpret and compare the diverse anti-
body titres reported in the literature. Several studies 
addressing the inter-laboratory variability of influenza 
HI and MN assays have found significant differences 
in geometric mean [8,121-124]. The interpretation of 
the test results is even more difficult because little 
is known about the agreement between HI and MN 
assays [122,124]. In addition, pre-existing antibodies 
against human influenza viruses may cross-react with 
animal influenza virus subtypes, resulting in titres that 
are unrelated to exposure or infection with an animal 
influenza virus [21-23]. Moreover, for many zoonotic 
influenza A subtypes the optimal detection method is 
unknown.
In this review, the focus was on assessing the specific-
ity of the reported findings. However, it is possible that 
clinical or subclinical infections are being missed and 
that the actual rate of infection is higher than the sero-
logical data suggest. For example, individuals exposed 
to H7 (other than H7N9) have developed a virologi-
cally confirmed conjunctivitis when no seroconversion 
could be detected [10,62]. Also, infections with avian 
influenza causing fever and/or respiratory symptoms 
can sometimes be confirmed virologically but not sero-
logically [10,110]. Moreover, serological responses to 
zoonotic influenza can wane rapidly, which can lead to 
underestimation of the frequency of spill-over of ani-
mal influenza viruses to humans [64,125].
Different levels of exposure also affect the level 
of human antibody titres against animal influenza 
viruses. Some studies compared occupational groups, 
and many of them find differences in seropreva-
lence between different occupational groups, which 
are postulated to reflect differences in exposure 
[31,42,43,49,56,62,67,68,70-73,79,93,96,116,117]. A 
problem is that influenza infections were rarely meas-
ured in the animals to which the study population was 
exposed at the time of the study, therefore making it 
difficult to assess the true levels of exposures. The 
lack of this information may in part explain the seem-
ingly contrasting conclusions reached regarding the 
occupational groups that have the highest seropreva-
lence to animal influenza: some studies find the high-
est antibody titres in veterinarians [43,72] while others 
find the highest titres in farmers [56,70], abattoir work-
ers [31] or poultry market workers [68]. Moreover, the 
term ‘occupational exposure’, as well as different occu-
pational groups are loosely defined, which makes them 
very hard to compare. Ahad et al. for example found 
high titres of avian influenza antibodies in poultry vac-
cinators, but very few other studies have looked at 
poultry vaccinators as a separate group occupationally 
exposed to poultry [96].
Looking at the studies collected for this review, it 
becomes clear there is no agreement on the diagnostic 
methods, cut-offs or study design that should be used 
to investigate the prevalence of zoonotic influenza in 
humans. This limits both the interpretation and the 
comparability of the available data. Following the H1N1 
pandemic in 2009, the WHO reached the same con-
clusions in a review on the pandemic and requested 
standardised methods to improve the comparability 
of the serological data [125]. Although the CONSISE 
published recommendations and protocols to stand-
ardise serological studies on zoonotic influenza virus 
outbreaks, human influenza virus epidemics, and sea-
sonal influenza, there are no guidelines for the design 
and execution of population studies for influenza on 
the human–animal interface [126,127].
An interesting finding is that studies graded C or D in 
this review generally reported higher seroprevalences 
to avian influenza viruses in humans than A or B stud-
ies. It is possible that using a less stringent study pro-
tocol leads to an overestimation of serological findings 
of animal influenza in humans. Therefore, to increase 
the reliability of the evidence and reduce the occur-
rence of false positive outcomes, inclusion of con-
founding factors either in the study design or the data 
analysis is important.
In this review we see that antibodies to swine influenza 
viruses A(H1N1)v, A(H1N2)v, and A(H3N2)v are more 
prevalent among persons occupationally exposed to 
pigs compared with those not exposed. However, given 
Table 2
Scores assigned to published studies on zoonotic influenza 
viruses, according to the initial screening laboratory 
method used to evidence zoonotic influenza, and the 
subsequent method for confirmation
Confirmation method
Screening method
NTa HI ELISA Noneb
NTa NA 5 5 3
HI 5 NA 4 2
ELISA 5 4 NA 2
Western blot 5 4 4 0
NI 3 3 3 0
Noneb 3 2 2 NA
ELISA: enzyme-linked immunosorbent assay; HI: 
haemagglutination inhibition assay; NA: not applicable; NI: 
neuraminidase inhibition assay; NT: neutralisation test.
a Neutralisation test: microneutralisation assay or virus 
neutralisation assay.
b No description of method provided.
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Table 3
Results of literature search on zoonotic influenza viruses, 1946–2014 (n=94 publications)
Influenza 
virus
Influenza 
subtype
Number 
of studies 
includeda
Laboratory methods usedb 
(number of studies)
Number of studies detecting 
antibodies in study group 
(proportion of included studies)
Number of studies detecting significant difference with control groupc 
(studies detecting significant difference with control group/total 
number of studies with control group)
Canine H3N8 1 MN/NT and NI (1) 1 (1/1) 0 (0/1)
Equine 
H3N8 4 MN/NT and HI (2) MN/NT (2) 4 (4/4) 0 (0/2)
H7N7 2 MN/NT and HI (2) 0 (0/2) 0 (0/0)
Swine 
H1N1v 35
MN/NT and HI (3) 
HI and NI (6) 
HI (22) 
MN/NT (3) 
ELISA (1)
32 (32/35) 13 (13/20)
H1N2v 6 MN/NT and HI (1) HI (5) 6 (6/6) 5 (5/6)
H2N3v 1 MN/NT and HI (1) 1 (1/1) 0 (0/1)
H3N2v 11
MN/NT and HI (2) 
HI and NI (1) 
HI (7) 
ELISA (1)
9 (9/11) 3 (3/7)
Avian 
H1 4
MN/NT and HI (1) 
MN/NT (2) 
Single radial analysis (1)
1 (1/4) 0 (0/1)
H2 5
MN/NT and HI (2) 
MN/NT (2) 
Single radial analysis (1)
2 (2/5) 0 (0/1)
H3 5
MN/NT and HI (2) 
HI and NI (2) 
Single radial analysis (1)
3 (3/5) 0 (0/1)
H4 22
MN/NT and HI (2) 
HI and NI (3) 
MN/NT (15) 
HI (1) 
Single radial analysis (1)
6 (6/22) 1 (1/14)
H5 
(not H5N1) 27
MN/NT and HI (5) 
MN/NT and Western blot (1) 
MN/NT (18) 
HI (2) 
Single radial analysis (1)
12 (12/27) 4 (4/16)
H6 21
MN/NT and HI (3) 
MN/NT (15) 
HI (2) 
Single radial analysis (1)
12 (12/21) 2 (2/13)
H7 40
MN/NT and HI (10) 
HI and NI (3) 
MN/NT (17) 
HI (9) 
Single radial analysis (1)
16 (16/40) 6 (6/23)
H8 16
MN/NT and HI (2) 
HI and NI (1) 
MN/NT (12) 
Single radial analysis (1)
2 (2/16) 1 (1/11)
H9 43
MN/NT and HI (10) 
MN/NT and Western blot (1) 
HI and ELISA (1) 
MN/NT (17) 
HI (13) 
Single radial analysis (1)
37 (36/43) 13 (13/29)
H10 19
MN/NT and HI (3) 
MN/NT (13) 
HI (2) 
Single radial analysis (1)
6 (6/19) 1 (1/12)
H11 19
MN/NT and HI (2) 
HI and NI (3) 
MN/NT (12) 
HI (1) 
Single radial analysis (1)
9 (9/19) 0 (0/11)
H12 14
MN/NT and HI (2) 
HI and NI (1) 
MN/NT (9) 
HI (1) 
Single radial analysis (1)
5 (5/14) 0 (0/7)
H13 4 MN and HI (2) HI (2) 1 (1/4) 0 (0/1)
H14 1 MN and HI (1) 0 (0/1) 0 (0/1)
H15 1 MN and HI (1) 0 (0/1) 0 (0/1)
H16 1 MN and HI (1) 0 (0/1) 0 (0/1)
ELISA: enzyme-linked immunosorbent assay; HI: haemagglutination inhibition assay; MN: microneutralisation assay; NI: neuraminidase inhibition assay; NT: neutralisation 
test.
a A given article could describe more than one study design, animal species, or influenza A subtype, so the total number of studies in this column is greater than 94.
b More detailed information can be found in the supplementary table (http://www.erasmusmc.nl/viroscience/research/suppl-table-animal-influenza-human-serology.
pdf/?view=active). 
c Studies in which a significant difference was explicitly mentioned or for which a significant difference could be calculated based on the data provided.
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the potential for cross-reactivity within subtype, sero-
logical studies that investigate human infection with 
swine influenza should be interpreted with great cau-
tion. Unlike avian influenza viruses, endemic swine 
influenza viruses often have common origins with 
seasonal human influenza viruses. Novel pandemic 
influenza human viruses have originated from swine 
viruses or have been introduced in swine, and play an 
important role in the evolution of genetic diversity of 
swine influenza viruses [128]. For instance, with the 
recent emergence of pandemic (H1N1) 2009 virus and 
subsequent reintroductions in the swine population, 
serological population studies investigating human 
infection with swine influenza viruses should be 
designed and interpreted with extreme caution to differ-
entiate true exposures from cross-reactions [129,130]. 
Nevertheless, the number of studies finding a sig-
nificant difference in seroprevalence between swine-
exposed study groups and unexposed control groups 
is strong evidence of frequent spill-over events from 
swine to humans. The high number of reported swine-
to-human transmissions and evidence for subsequent 
human-to-human transmission, in combination with 
the recent emergence of pandemic (H1N1) 2009 virus, 
warrants increased serological and virological surveil-
lance of swine and people that are exposed to swine 
[6,131]. Unfortunately swine influenza surveillance is 
less prevalent than avian influenza surveillance, and 
there is relatively little knowledge on prevalence and 
circulation of swine influenza [132].
According to our assessment, the most reliable sero-
logical evidence (grade A and B) was found for human 
exposure to avian influenza virus HA-types H5, H7, and 
H9. The risk of infection with H5 and H7 subtypes is 
illustrated by the serious recent outbreaks of subtypes 
(H5N1) virus and A(H7N9) virus in humans, which, as of 
late 2016, have resulted in 452 and 320 deaths, respec-
tively [133]. Few cases of humans infected with avian 
H9 viruses have been reported: Freidl et al. described 
in their literature review the virological evidence of 
15 cases of humans infected with H9N2 [6]. However, 
avian H9N2 viruses are a growing concern, and the 
mild disease associated with H9 infection poten-
tially leads to considerable underestimation of inci-
dence [50,134,135]. H9 avian influenza can be found 
in poultry all over the world and is also described in 
multiple other avian species, pigs and dogs [136-139]. 
Moreover, internal genes of A(H9N2) were found in 
A(H10N8), A(H7N9) and A(H5N1), showing that A(H9N2) 
can reassort with other influenza subtypes, potentially 
resulting in the generation of new zoonotic influenza 
types [140-142]. In 2013, human cases of infection with 
H10N8 and H6N1 were reported, as well as presence of 
these serotypes in environmental samples from ani-
mal markets, showing that H6 and H10 serotypes can 
likewise pose a risk to human health [140,143-145]. 
Serological cohort studies of persons exposed to poul-
try provide information on the incidence and longevity 
of antibodies to zoonotic influenza viruses. For most 
avian influenza subtypes, this information is currently 
unknown and will greatly contribute to the risk analysis 
of zoonotic avian influenza.
Although human antibodies have been found against 
equine and canine influenza, these infections seem 
to be a minor public health risk. However, the very 
limited number of studies could lead to substantial 
under-reporting.
Conclusion
Comparing human serological data is difficult due to a 
lack of standardisation in the collection of epidemio-
logical data and the laboratory methods used in pub-
lished zoonotic influenza studies. Researchers should 
take into account WHO guidelines, known confounding 
factors and the need for a control group in order to pro-
duce research articles that can be used and compared 
by policymakers and other researchers to better assess 
the risks and prevalence of animal influenza exposure 
in humans.
Swine-to-human transmission is prevalent, but 
national surveillance systems and standard serological 
surveillance of swine and human risk groups is scarce. 
Surveillance for avian influenza is more common, but 
most veterinary surveillance systems target H5 andH7 
serotypes and, accordingly, most serological evidence 
is reported for these subtypes. Given the zoonotic 
potential of avian influenza viruses, which can poten-
tially reassort with circulating seasonal human influ-
enza virus subtypes, systematic surveillance in poultry 
populations should be expanded beyond H5 and H7, 
the primary focus for the veterinary sector [146,147]. 
Subtypes H6, H9 and H10 are known to be able to infect 
humans and should therefore be included. Moreover, 
structured surveillance of human risk groups to detect 
spill over of influenza viruses is rare and should be 
implemented in national surveillance systems. Finally, 
we found that the majority of studies conducted at the 
human–animal interface represent Asia, Europe, and 
North America. Efforts should be made to shed light on 
understudied areas, such as South America and Africa.
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